Iquix Related Published Studies
Well-designed clinical trials related to Iquix (Levofloxacin Ophthalmic)
A prospective study determining the efficacy of topical 0.5% levofloxacin on bacterial flora of patients with chronic blepharoconjunctivitis. [2009.07]
Increased anterior chamber penetration of topical levofloxacin 0.5% after pulsed dosing in cataract patients. [2009.03]
Clinical and microbiological efficacy of levofloxacin administered three times a day for the treatment of bacterial conjunctivitis. [2009.01]
Ocular penetration of levofloxacin, ofloxacin and ciprofloxacin in eyes with functioning filtering blebs: investigator masked, randomised clinical trial. [2008.03]
A prospective randomized study to determine the efficacy of preoperative topical levofloxacin in reducing conjunctival bacterial flora. [2008.01]
Prospective randomized comparison of 1-day versus 3-day application of topical levofloxacin in eliminating conjunctival flora. [2007.09]
Aqueous and vitreous penetration of levofloxacin after topical and/or oral administration. [2007.05]
Penetration of topically applied levofloxacin 0.5% and ofloxacin 0.3% into the vitreous of the non-inflamed human eye. [2006.12]
Corneal penetration of fluoroquinolones: aqueous humor concentrations after topical application of levofloxacin 0.5% and ofloxacin 0.3% eyedrops. [2005.07]
Well-designed clinical trials possibly related to Iquix (Levofloxacin Ophthalmic)
A comparison of fluoroquinolone penetration into human conjunctival tissue. [2008.12]
[Will intracameral cefuroxime become the new standard in endophthalmitis prevention?] [2008.11]
Clinical efficacy of moxifloxacin in the treatment of bacterial keratitis: a randomized clinical trial. [2007.09]
Differential Aqueous and Vitreous Concentrations of Moxifloxacin and Ofloxacin After Topical Administration One Hour before Vitrectomy. [2007.08]
Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. [2007.06]
[Clinical research of isatis root eyedrops on the acute bacterial conjunctivitis] [2007.01]
Prospective randomized comparison of 2 different methods of 5% povidone-iodine applications for anterior segment intraocular surgery. [2005.02]
Other research related to Iquix (Levofloxacin Ophthalmic)
Clinical and microbiological efficacy of levofloxacin administered three times a day for the treatment of bacterial conjunctivitis. [2009]
Postantibiotic effects and bactericidal activities of levofloxacin and gatifloxacin at concentrations simulating those of topical ophthalmic administration against fluoroquinolone-resistant and fluoroquinolone-sensitive methicillin-resistant Staphylococcus aureus strains. [2008.08]
Bactericidal effect of intravitreal levofloxacin in an experimental model of endophthalmitis. [2008.05]
Comparison of the effect of intracameral moxifloxacin, levofloxacin and cefazolin on rabbit corneal endothelial cells. [2008.05]
Penetration of topically applied levofloxacin into eyes with thin-wall filtering bleb after trabeculectomy. [2008.05]
The ocular penetration of levofloxacin 1.5% and gatifloxacin 0.3% ophthalmic solutions in subjects undergoing corneal transplant surgery. [2007.12]
Penetration of levofloxacin into the anterior chamber (aqueous humour) of the human eye after intravenous administration. [2007.02]
Penetration of topically applied levofloxacin 0.5% and ofloxacin 0.3% into the vitreous of the non-inflamed human eye. [2006.05.20]
Safety and efficacy of levofloxacin 1.5% eyedrops in nonhuman primates having penetrating keratoplasty: clinical and laboratory findings. [2005.10]
Flomoxef sodium and levofloxacin concentrations in aqueous humor. [2005.04]
Other possibly related research studies
Failure of Listeria monocytogenes keratitis to respond to topical ofloxacin. [2006.08]
Recalcitrant post-LASIK Mycobacterium chelonae keratitis eradicated after the use of fourth-generation fluoroquinolone. [2006.06]
Extending the limits of fingertip composite grafting with moist-exposed dressing. [2005.12]
Effectiveness of fluoroquinolones against Mycobacterium abscessus in vivo. [2006.01]
Fusidic acid vs ofloxacin prophylaxis before cataract surgery. [2005.11]
Ocular pharmacokinetics of moxifloxacin after topical treatment of animals and humans. [2005.11]
An ophthalmologist's guide to understanding antibiotic susceptibility and minimum inhibitory concentration data. [2005.11]
Reduction of conjunctival bacterial flora by povidone-iodine, ofloxacin and chlorhexidine in an outpatient setting. [2005.06]
Ciprofloxacin and ofloxacin aqueous humor concentrations after topical administration in dogs undergoing cataract surgery. [2005.05]
The successful treatment of gatifloxacin-resistant Staphylococcus aureus keratitis with Zymar (gatifloxacin 0.3%) in a NZW rabbit model. [2005.05]
Effectiveness of topical taurolidine versus ciprofloxacin, ofloxacin, and fortified cefazolin in a rabbit Staphylococcus aureus keratitis model. [2005.03]
Presumed oculoglandular syndrome from Bartonella quintana. [2007.01]
Methicillin-resistant Staphylococcus aureus infectious keratitis following refractive surgery. [2007.04]
[The effects of amniotic membrane on corneal penetration of ofloxacin] [2006.07]
High-level fluoroquinolone resistance in ophthalmic clinical isolates belonging to the species Corynebacterium macginleyi. [2007.12.12]
Prospective study demonstrating the efficacy of combined preoperative three-day application of antibiotics and povidone-iodine irrigation. [2007.12]
Postoperative endophthalmitis caused by Bacillus cereus and Chlamydia trachomatis. [2007.07]
Comparative minimal inhibitory and mutant prevention drug concentrations of four fluoroquinolones against ocular isolates of Haemophilus influenzae. [2007.05]
[The effectiveness of the new fluoroquinolones against the normal bacterial flora of the conjunctiva] [2007.01]
Corneal deposits and topical ofloxacin--the effect of polypharmacy in the management of microbial keratitis. [2007.03]
Three cases of idiopathic "multiple-parallel-line" endotheliitis. [2008.01]
High-level fluoroquinolone resistance in ophthalmic clinical isolates belonging to the species Corynebacterium macginleyi. [2008.02]
Post-LASIK epithelial dendritic defect associated with Alternaria. [2007.10]
Mycobacterium chelonae keratitis in a patient with Sjogren's syndrome. [2008.03]
Methicillin-resistant ascending facial and orbital cellulitis in an operation Iraqi Freedom troop population. [2007.09]
Ocular toxicity of fluoroquinolones. [2007.08]
Bilateral Acanthamoeba keratitis in an experienced two-weekly disposable contact lens wearer. [2007.07]
Infectious crystalline keratopathy caused by Gemella haemolysans. [2007.06]
Acute endophthalmitis after 25-gauge sutureless vitrectomy. [2007.12]
Delayed intraocular foreign body removal without endophthalmitis during Operations Iraqi Freedom and Enduring Freedom. [2007.08]
Preoperative disinfection of the conjunctival sac with antibiotics and iodine compounds: A prospective randomized multicenter study. [2008.05]
Isolates and antibiotic sensitivity of eighty culture-proven endophthalmitis cases from Istanbul. [2008]
Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates. [2008.06]
Review of third-and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy. [2008.10]
Posttraumatic cellulitis and ulcerative conjunctivitis caused by Yersinia enterocolitica O:8. [2008.09]
[Analysis on susceptibility of ocular bacterial pathogens to four kinds of fluoroquinolone] [2008.03]
Listeria monocytogenes sclerokeratitis: a case report and literature review. [2008.09]
Third- and fourth-generation fluoroquinolones: retrospective comparison of endophthalmitis after cataract surgery performed over 10 years. [2008.09]
[Different concentrations of clarithromycin ophthalmic gel for rabbits corneal ulcers induced by staphylococcus aureus] [2008.03]
Assessment of the use of anterior segment optical coherence tomography in microbial keratitis. [2008.10]
Prophylactic efficacy of ophthalmic quinolones in experimental endophthalmitis in rabbits. [2008.06]
Evidencing the modulation of P-glycoprotein at blood-ocular barriers using gamma scintigraphy. [2009.01]
[Epiphora in a patient receiving FOLFOX therapy] [2008.11]
Preventive effect against post-cataract endophthalmitis: drug delivery intraocular lens versus intracameral antibiotics. [2008.10]
Clinicobacteriological study of chronic dacryocystitis in adults. [2008.05]
Nocardia transvalensis resistant to amikacin: an unusual cause of microbial keratitis. [2008.10]
Peginterferon-alpha-2a (40 kD) Plus Ribavirin: A Review of its Use in the Management of Chronic Hepatitis C Mono-Infection. [2008]
Management of evaporative dry eye in ectrodactyly-ectodermal dysplasia-clefting syndrome. [2008.09]
Gemella species-associated late-onset endophthalmitis after trabeculectomy with adjunctive mitomycin C. [2009.08]
[Buruli ulcer involving the head: outcomes and therapeutic aspects in 8 cases observed at the University Hospital Center in Abidjan, Cote d'Ivoire] [2008.12]
Endophthalmitis after compression sutures for enlarged conjunctival filtration bleb following trabeculectomy. [2009.07]
Influence of borneol on in vitro corneal permeability and on in vivo and in vitro corneal toxicity. [2009.05]
Eustachian tube foreign body undetected for 30 years: case report. [2009.04]
[Bacterial corneal ulcer treated with intrastromal antibiotic. Experimental model in vivo] [2009.03]
Sustained ophthalmic delivery of ofloxacin from an ion-activated in situ gelling system. [2009.04]
Contact lens-associated microbial keratitis. [2008.11]
The evaluation of the treatment response in obstructive meibomian gland disease by in vivo laser confocal microscopy. [2009.06]
Bipolaris hawaiiensis keratomycosis and endophthalmitis. [2009.01]
Mycobacterium chelonae keratitis in a patient with Sjogren's syndrome. [2008.03]
|
